Literature DB >> 9384930

Biobehavioral treatment and rehabilitation of schizophrenia.

A Kopelowicz1, R P Liberman.   

Abstract

The psychopathology and associated disabilities experienced by persons with schizophrenia have only partially responded to conventional pharmacological and psychosocial treatment approaches. Biobehavioral treatment and rehabilitation employs behavioral assessment, social learning principles, skills training, and a focus on the recovery process to amplify the effects of pharmacotherapy. Utilizing the Medline database, we review a selection of English-language studies published from 1970 to 1994 that support the effectiveness of each of the components of biobehavioral therapy, such as case management, psychopharmacology with behavioral assessment, psychoeducation, family involvement, and social skills training. An integrated biobehavioral therapy directed toward early detection and treatment of schizophrenic symptoms, collaboration between consumers and caregivers in managing treatment, family and social skills training, and teaching coping skills and self-help techniques has been documented to improve the course and outcome of schizophrenia, as measured by symptom recurrence, social functioning, and quality of life. A case vignette is presented to illustrate the successful integration of biobehavioral therapies into a treatment system that focuses on consumers' attempts to become increasingly responsible for recovering from illness.

Entities:  

Mesh:

Year:  1995        PMID: 9384930     DOI: 10.3109/10673229509017168

Source DB:  PubMed          Journal:  Harv Rev Psychiatry        ISSN: 1067-3229            Impact factor:   3.732


  3 in total

1.  Behavioral Research on the Severe and Persistent Mental Illnesses.

Authors:  Michael P Carey; Kate B Carey
Journal:  Behav Ther       Date:  1999

2.  Psychiatric rehabilitation today: an overview.

Authors:  Wulf Rössler
Journal:  World Psychiatry       Date:  2006-10       Impact factor: 49.548

3.  Exploration of experiences in therapeutic groups for patients with severe mental illness: development of the Ferrara group experiences scale (FE- GES).

Authors:  Rosangela Caruso; Luigi Grassi; Bruno Biancosino; Luciana Marmai; Luciano Bonatti; Maria Moscara; Marco Rigatelli; Catherine Carr; Stefan Priebe
Journal:  BMC Psychiatry       Date:  2013-10-01       Impact factor: 3.630

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.